## Distinguishing Feature: Hormonal Suppression of Gonadotropins ### Combined Oral Contraceptives (COCs) **Key Point:** COCs contain both estrogen (ethinylestradiol) and progestin. The estrogen component provides potent suppression of FSH and LH at the hypothalamic-pituitary level, preventing follicular development and ovulation. ### Progestin-Only Pills (POPs) **Key Point:** POPs rely primarily on progestin alone, which: - Does NOT reliably suppress gonadotropins - Works mainly through cervical mucus thickening - May allow occasional ovulation (less reliable contraception) - Have higher failure rates (~9% typical use vs. 7% for COCs) ### Comparison Table | Feature | COCs | POPs | | --- | --- | --- | | **Estrogen content** | Yes (ethinylestradiol) | No | | **FSH/LH suppression** | Potent and reliable | Minimal/inconsistent | | **Primary mechanism** | Ovulation inhibition | Cervical mucus + endometrial changes | | **Failure rate (typical use)** | ~7% | ~9% | | **Use in lactation** | Relative contraindication | Preferred (minimal hormone in milk) | | **Efficacy** | Higher | Lower | **High-Yield:** The presence of estrogen in COCs enables robust suppression of the hypothalamic-pituitary-ovarian (HPO) axis, making ovulation inhibition the primary contraceptive mechanism. POPs cannot achieve this because progestin alone does not suppress gonadotropins sufficiently. **Clinical Pearl:** POPs are preferred in breastfeeding women because they do not suppress lactation (estrogen inhibits prolactin), whereas COCs may reduce milk supply. [cite:KD Tripathi 8e Ch 62]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.